- Home
- ASRT vs CBUS Comparison
ASRT vs CBUS Comparison
Compare ASRT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- CBUS
- Stock Information
- Founded
- ASRT 1995
- CBUS 2010
- Country
- ASRT United States
- CBUS United States
- Employees
- ASRT N/A
- CBUS N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- CBUS Agricultural Chemicals
- Sector
- ASRT Health Care
- CBUS Industrials
- Exchange
- ASRT Nasdaq
- CBUS Nasdaq
- Market Cap
- ASRT 57.9M
- CBUS 65.3M
- IPO Year
- ASRT 1997
- CBUS 2017
- Fundamental
- Price
- ASRT $0.66
- CBUS $3.34
- Analyst Decision
- ASRT Strong Buy
- CBUS Strong Buy
- Analyst Count
- ASRT 3
- CBUS 3
- Target Price
- ASRT $3.08
- CBUS $22.00
- AVG Volume (30 Days)
- ASRT 284.6K
- CBUS 155.8K
- Earning Date
- ASRT 05-12-2025
- CBUS 05-08-2025
- Dividend Yield
- ASRT N/A
- CBUS N/A
- EPS Growth
- ASRT N/A
- CBUS N/A
- EPS
- ASRT N/A
- CBUS N/A
- Revenue
- ASRT $119,001,000.00
- CBUS $4,751,000.00
- Revenue This Year
- ASRT N/A
- CBUS $32.97
- Revenue Next Year
- ASRT $11.71
- CBUS $66.40
- P/E Ratio
- ASRT N/A
- CBUS N/A
- Revenue Growth
- ASRT N/A
- CBUS 104.78
- 52 Week Low
- ASRT $0.51
- CBUS $1.40
- 52 Week High
- ASRT $1.80
- CBUS $15.06
- Technical
- Relative Strength Index (RSI)
- ASRT 50.57
- CBUS 63.81
- Support Level
- ASRT $0.67
- CBUS $2.16
- Resistance Level
- ASRT $0.71
- CBUS $3.40
- Average True Range (ATR)
- ASRT 0.04
- CBUS 0.33
- MACD
- ASRT 0.00
- CBUS 0.06
- Stochastic Oscillator
- ASRT 52.69
- CBUS 85.60
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.